[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.176.107. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
September 1981

Therapeutic Considerations in Recessive Dystrophic Epidermolysis Bullosa

Arch Dermatol. 1981;117(9):529-530. doi:10.1001/archderm.1981.01650090011014
Abstract

Hereditary epidermolysis bullosa"—the general term referring to perhaps as many as nine different1 mechanobullous disorders of the skin—is a devastating disease to the patients and families afflicted with one of its genetic forms. During the past two decades, the investigations of dermatologists, geneticists, immunologists, and cell biologists have contributed substantially to our understanding of basic disease mechanisms in certain forms of epidermolysis bullosa. Because of this, it has been possible in some cases to take a more direct approach and to begin to tailor therapy to putative pathogenic mechanisms.

Recessive dystrophic epidermolysis bullosa has been shown by ultrastructural2,5 and biochemical6-10 methods to be a disorder in which the pathogenesis of blistering is, at least in part, related to trauma-induced destruction of collagen in the papillary dermis. Based on the observation that human skin collagenase is overproduced in the skin of patients with this form of epidermolysis bullosa,8

First Page Preview View Large
First page PDF preview
First page PDF preview
×